Netufo, O.; Connor, K.; Shiels, L.P.; Sweeney, K.J.; Wu, D.; O’Shea, D.F.; Byrne, A.T.; Miller, I.S.
Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents. Pharmaceuticals 2022, 15, 550.
https://doi.org/10.3390/ph15050550
AMA Style
Netufo O, Connor K, Shiels LP, Sweeney KJ, Wu D, O’Shea DF, Byrne AT, Miller IS.
Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents. Pharmaceuticals. 2022; 15(5):550.
https://doi.org/10.3390/ph15050550
Chicago/Turabian Style
Netufo, Oluwakanyinsolami, Kate Connor, Liam P. Shiels, Kieron J. Sweeney, Dan Wu, Donal F. O’Shea, Annette T. Byrne, and Ian S. Miller.
2022. "Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents" Pharmaceuticals 15, no. 5: 550.
https://doi.org/10.3390/ph15050550
APA Style
Netufo, O., Connor, K., Shiels, L. P., Sweeney, K. J., Wu, D., O’Shea, D. F., Byrne, A. T., & Miller, I. S.
(2022). Refining Glioblastoma Surgery through the Use of Intra-Operative Fluorescence Imaging Agents. Pharmaceuticals, 15(5), 550.
https://doi.org/10.3390/ph15050550